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We investigated pain evoked activity in the human secondary sensory cortex (SII) following clonidine administration in six
healthy volunteers using multi-channel magnetoencephalography (MEG). Pain was elicited by electrical shocks applied intracuta-
neously to the ﬁngertip. Subjects rated pain intensity and perceptions of tiredness and passiveness by numerical ranking scales. Each
subject underwent two investigations, one week apart from each other, with clonidine doses of 1.5 or 3.0 lg/kg, administered intra-
venously in a random order and double-blinded. We applied a total number of seven blocks, each consisting of 60 painful stimuli,
with one adaptation block, one pre-medication block, four post-medication blocks and one recovery block at the end of the session.
MEG data were analysed by dipole reconstruction using CURRYR (Neuroscan, Hamburg) software package. Cortical activity in
the contralateral SII cortex appeared with peak latencies of 118.5 ± 10 ms. This activity was signiﬁcantly reduced by clonidine, in
parallel with a reduction of pain intensity and enhancement of subjective tiredness and passiveness. There was, however, no signif-
icant correlation between MEG and subjective eﬀects. Although both clonidine doses had similar eﬀects, the higher dose induced
longer changes. Results indicate that intravenous clonidine is able to relieve pain, but the exact mechanism of clonidine at the level
of the SII cortex remains unclear. It is possible that clonidine interacts with the brainstem ascending system regulating vigilance and
arousal which would explain the observed decrement of pain induced activity in SII. An additional more speciﬁc analgesic action at
spinal level cannot be excluded.
 2005 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Ltd. All
rights reserved.
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The perception of pain contains sensory, cognitive
and aﬀective components (Melzack and Casey, 1967).
It is possible to assign some of these components to cir-
cumscript activities in diﬀerent brain regions (Talbot
et al., 1991; Casey et al., 1996; Bromm et al., 2000).1090-3801/$32  2005 European Federation of Chapters of the International
reserved.
doi:10.1016/j.ejpain.2005.12.003
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E-mail address: bromm@uke.uni-hamburg.de (B. Bromm).According to their main neuronal input from lateral tha-
lamic nuclei, the primary (SI) and secondary somatosen-
sory cortices (SII) are parts of the lateral pain system
(Treede et al., 2000) which governs mainly sensory-dis-
criminative functions, i.e., the processing of information
about duration, strength and location of pain. In con-
trast, the cingulate gyrus is part of the medial pain sys-
tem and plays an important role in the cognitive and
aﬀective aspects of pain perception (Bush et al., 2000).
Most knowledge about SII comes from invasive animal
studies focussing on tactile functions (for review seeAssociation for the Study of Pain. Published by Elsevier Ltd. All rights
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tometry, the human SII cortex can be investigated non-
invasively for the ﬁrst time, especially in the context of
pain (Hari et al., 1983a,b; Laudahn et al., 1995; Kakigi
et al., 2000). Pain relevant SII areas are located superﬁ-
cially in the cortex, and the respective columns show a
tangential direction to the head surface, allowing the
detection of relatively large magnetic ﬁelds during neu-
ronal activity (see, for example, Hillebrand and Barnes,
2002). Pain related SII activity has meanwhile been
described by many authors using functional brain imag-
ing methods, in particular multi channel MEG record-
ings. The activity starts between 90 and 150 ms after
the pain stimulus, depending on the body site and acti-
vated nerve ﬁbre spectrum (Howland et al., 1995;
Bromm et al., 1996; Kakigi et al., 1996; Lenz et al.,
1998; Frot et al., 1999; for review see Bromm and Lor-
enz, 1998). Also, it is well known that pain-induced SII
activity depends strongly on the vigilance level and the
attentional state of the brain (Bromm et al., 2000;
Ha¨ma¨la¨inen et al., 2000; Nakamura et al., 2002).
The following study addresses the question whether
pain evoked SII activity is altered by clonidine, an
a2-agonist with both antinociceptive and sedative prop-
erties. Clonidine is typically used as co-analgesic in post-
operative pain management (see, e.g., Bischoﬀ and
Kochs, 1993; Kanui et al., 1993; Eisenach et al., 2000).
Using dipole reconstruction analysis of magnetic brain
maps gathered from multichannel MEG, we investi-
gated the eﬀects of two diﬀerent doses of intravenously
administered clonidine on the SII-Cortex.2. Methods
2.1. Subjects and test procedure
The study was performed on seven healthy male stu-
dents (six right handed, one left handed) with written
informed consent (age 26 ± 3 years, height 183 ± 7 cm,
weight 76 ± 5 kg) after being approved by the Institu-
tional Ethics Committee. Control of standard clinical
and neurological status, serum chemistry, and MRI scan
of the brain yielded normal ﬁndings and there was no
history of neurologic or psychiatric abnormalities. The
MRI scan was additionally used to calculate the dipoles
in the individual anatomy. One subject was discarded,
because of strong artefacts during MEG recordings.
We tested subjects in two separate sessions, one week
apart from each other, with two doses of clonidine
(1.5 and 3.0 lg/kg), administered intravenously. The
order of doses was randomized and double-blinded.
Subjects underwent a clinical examination before and
3 h after medication in which blood pressure, blood oxy-
genation and heart rate was monitored (Jenacor, Jena,
Germany). Pain was induced according to the intracuta-neous pain model (Bromm and Meier, 1986; Scharein
and Bromm, 1998). Brieﬂy, a thin needle electrode was
fed through a hole punched into the horny skin of the
tip of the middle ﬁnger of the non-dominant hand and
an electrical pulse (5 ms duration) delivered to the near-
est neighbourhood of nociceptors. We applied two dif-
ferent stimulus intensities according to 2 (I1) and 3 (I2)
times individual pain threshold (Ip) the latter being
determined by a series of increasing stimulus intensities
and decreasing stimulus intensities at the beginning of
each session. The subjects had to rate the stimulus inten-
sity according to a numerical ranking scale (NRS) with
values from 0 to 10. Values of more than three described
a painful sensation and determined the pain threshold
Ip. The average pain threshold intensity was 0.2 mA
(±0.07 mA standard deviation).
During the experiments subjects lay in a noise-
reduced, electrically and magnetically shielded chamber
containing the cryostat supplied with 31 gradiometers.
The stimuli were given in blocks of 60 with the two
intensities I1 and I2 in a quasi random sequence; the
inter-stimulus interval varied between 6 and 10 s. Thus
each block lasted approximately 12 min. Recordings of
the single trials were averaged within each block as aver-
age block data to reduce the signal to noise ratio. On
each investigation day, seven blocks of stimuli were
applied with intervals of 3–5 min between the ﬁrst six
blocks. The ﬁrst one (block 0) was done for adaptation
only and excluded from further evaluation, to minimize
the largest source of variability due to habituation
(Bromm and Lorenz, 1998). The next block served to
achieve pre-medication values (block PRE). Immedi-
ately after administration of clonidine, six consecutive
blocks explored the eﬀects over a post-medication time
period lasting from 0 min (POST1) to 55 min (POST4)
after medication. At the end of the session (90 min after
medication) the last stimulus block was performed
(RECOVERY). Three seconds after each pain stimulus,
a tone prompted the subjects to rate their sensation
using the NRS. Moreover, subjective tiredness and pas-
siveness was measured by visual analog scales (0–100).
Higher values describe a greater extent of tiredness
and passiveness, whereas values around 0 describe no
tiredness and passiveness at all. The subjects were asked
to describe their perceptions before the ﬁrst block as well
as 60 and 120 min after clonidine injection.
2.2. Data recording and evaluation
MEG data were measured with a 31-channel bio-
magnetometer (Philips, Hamburg); the gradiometers
were centred over the hemisphere contralateral to the
stimulated side (C3, C4). A 32 channel EEG was also
recorded to control for changes in vigilance. Responses
were restricted to a frequency band between 0.3 and
100 Hz and digitized at a sampling rate of 200 Hz. A
Fig. 1. Data of the premedication block, single subject HE. Above (A)
is shown the butterﬂyplot of all 31 MEG channels with two ﬁeld
maxima. The isocontour map of the second maxima after 105 ms is
shown in the middle (B) and projected on the subjects head. Dipole
reconstruction of this ﬁeld with interindividual anatomy parameters
found a dipole in SII (C).
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was ﬁtted to the head shape of each subject. Further
dipole reconstructions were calculated with the CUR-
RYR software package (Neuroscan, Hamburg). After
visual artifact control (on the average less than 10% of
all recordings were discarded), 70 Hz low pass ﬁltering
and common mode rejection, data of the pre-medication
blocks were subjected to the one moving dipole approx-
imation, which is suﬃcient for SII evaluations as deter-
mined by earlier studies (Bromm and Lorenz, 1998).
With a relative maximum of the mean global ﬁeld power
(GFP) between 80 and 160 ms, the best ﬁtting dipole
had to fulﬁl the following attributes: a goodness of ﬁt
(GOF) better than 90%, a spatial stability (D) lower then
10 mm, and a lifetime of at least 15 ms. Spatial stability
(D) describes the euclidean distance of the dipole coordi-
nates between adjacent sample points. Life-time means
that these parameters have to occur for at least 15 ms.
If these attributes were fulﬁlled, the dipole could be
regarded as stable over time. As a last step, all dipole
coordinates were transformed into the Talairach coordi-
nate system (Talairach and Tournoux, 1988), using the
individual head morphology.
The dipole found in the MEG data block PRE was
then ﬁxed for analysis of the cortical activity after cloni-
dine administration. This had to be done, since the
evoked ﬁelds were drastically reduced under clonidine
with a low signal to noise ratio. Moreover, we did not
assume that clonidine shifts the location of pain-induced
SII activity. For further statistical analysis SPSS 10.0
was used (SPSS, Chicago, IL). After ﬁrst testing all data
for normal distribution using a Kolmogorov–Smirnov
test, the global data set was subjected to a two factorial
analysis of variance (ANOVA). Signiﬁcant results were
further analyzed with paired student t-tests for depen-
dent samples. Correlations between SII dipole strength
and pain perception were calculated as well.3. Results
Results of a single subject (HE) with the original
recorded data of the pre-medication block are shown
as butterﬂy plot in Fig. 1A. It illustrates a maximum
of evoked magnetic activity at approximately one hun-
dred ms after stimulus onset. Fig. 1B displays the iso-
contour map of this ﬁeld at peak maximum of 105 ms
projected on the individual’s head (obtained from the
MRI scans). It indicates a distinct inversion in polarity
(continuous lines indicate outward ﬁelds, dashed lines
ﬁeld entrances) that is characteristic for a dipolar ﬁeld.
Source reconstruction of this evoked ﬁeld revealed a
dipole, the location of which is shown in Fig. 1C. This
dipole had a maximal dipole strength (Q = 29.1 lA mm)
at 105 ms and a goodness of ﬁt (GOF) of 98.3% between
measured and calculated ﬁelds around peak latencytime. The coordinates of the identiﬁed dipole in the
Talairach system were: X = 54.1; Y = 9.0; Z = 22.6,
which is clearly in the SII area of the dominant hemi-
sphere (Table 1) The dipole direction was parallel to
the cortex surface and oriented from superior to ventral.
It should be noted that a similar dipole appears in the
ipsilateral hemisphere (bilateral SII co-activation; Kak-
igi et al., 1995; Bromm et al., 2000) but cannot be iden-
tiﬁed with only one cryostat positioned over the C3
location of the 10–20 system, as used in this study.
Similar ﬁndings were made in all subjects regarding
the pre-medication blocks of the study. The peak max-
ima in mean global ﬁelds varied from subject to subject
in a range between 90 and 130 ms. Results are given in
Fig. 2, illustrating the high re-detection accuracy of
measurements. In principle, all dipoles were found in
SII; only one of the 14 pre-medication blocks (subject
PR, day 2) failed to be localized within SII. The dipole
coordinates and additional parameters are summarised
Table 1
Dipole coordinates in the Talairach-system (x, y, z); dipole strength (Q); mean global ﬁeld maxima (MGF); goodness of ﬁt (GOF) and the latency
time (time) are shown for both medication conditions (lg/kg) for each subject at the premedication block
Subject (lg/kg) x (mm) y (mm) z (mm) Q (lA mm) GOF (%) MGF (fT) Time (ms)
HE 3 54.1 9 22.6 29.1 98.3 134 100
HE 1.5 41.7 16.3 27.7 21.8 98.7 92.5 105
ME 3 61.9 16.6 9.1 11.8 96.1 61 120
ME 1.5 55.5 11.6 5.2 27.3 97.3 106 120
PR 3 55.3 10.8 32.5 8.84 93.8 64.4 130
PR 1.5
SA 3 35.5 5.6 16.3 44.4 98.7 118 105
SA 1.5 37.4 4.8 21.2 29.1 98.6 84 115
WA 3 58.8 5.1 38.3 8.05 86.9 46.1 125
WA 1.5 56 1.5 26.8 6.2 83.1 31.8 125
KU 3 ()60.1 3.9 17.3 35.2 97.6 139 125
KU 1.5 ()54.4 10.4 13.1 33.2 98.8 128 125
Mean 52.2 5.3 21.9 22.57 91.75 84.61 118.75
SD 8.8 8.9 10.1 12.38 13.17 42.26 10.25
Values are the mean value with standard deviation.
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variations were within the spatial resolution of our tech-
niques (<6 mm, for further details see Fuchs et al.,
1998).
The eﬀects of clonidine are shown in Fig. 3 for subject
HE. Already 20 min after medication, within stimulus
block POST2, pain induced SII activity disappeared
completely. As a consequence the signal to noise ratio
was very low after clonidine application in all subjects.
In order to calculate a reasonable dipole model, we
had to apply the ﬁxed dipole approximation (see meth-
ods) with the individual coordinates given in Table 1;Fig. 2. Dipole localisations of all subjects were found in SII. It is only sho
(3.0 lg/kg) and lower (1.5 lg/kg) clonidine dose, which was applicated afte
further source analysis to investigate the eﬀect of clonidine. Subject KU wasin case of PR, day 2, we used those coordinates found in
day 1. In this way the clonidine induced reduction in SII
dipole-strength was quantiﬁed. The eﬀects of the two clo-
nidine doses upon the SII dipole strengths are shown as a
function of medication time in Fig. 4A. At the higher
dose of clonidine. the dipole strength decreased from
22.9 ± 15.4 lA mm in the PRE block to 19.2 ±
14.5 lA mm in POST block1 and 5.5 ± 14.5 lA mm in
POST block2, which was 22% of the PRE value. Post
Block 3 and 4 and theRECBlock yielded a gradual recov-
ery of the dipole strength to mean values of 7.9 ± 4.3,
13.1 ± 11.4 and 11.4 ± 9.0 lA mm, respectively. Awn the premedication block of the experiment conditions with higher
r this block. These interindividual dipole localisations were ﬁxed for
left handed, so the dipole was found in the contralateral side.
Fig. 3. Butterﬂy plots with corresponding iso contourmaps and dipole localisations are shown for the premedication block (A) and 20 min after
clonidine application (B). The SII-activity is reduced after clonidine application. Shown is subject HE.
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The dipole strength decreased from 22.2 ± 9.9 lA mm in
the PRE block to 13.6 ± 10.0 lA mm in POST block1, to
6.8 ± 5.1 lA mm in POST block2 and to
6.4 ± 2.9 lA mm in POST block3, the latter being 28%
of the PRE value. Again, there was a recovery of the
dipole strength to 7.7 ± 5.6 lA mm in POST block4 and
16.9 ± 14.6 lA mm in the REC block. Thus, clonidine
dose had no eﬀect on the reduction of the SII dipole
strength, but appeared to extend its duration.
Fig. 4B shows the pain ratings for all subjects, which
were measured during the treatments in each individual,
as described above. At the higher dose of clonidine, pain
ratings decreased from 4.7 ± 0.7 in the PRE block to
3.6 ± 0.4 in POST block1 and 2.3 ± 1.6 in POST block2,
which was 48% of the PRE value followed by a recovery
of the pain ratings to 2.6 ± 1.1 in POST block3,
3.4 ± 0.8 in POST block4 and 4.2 ± 0.4 in the REC
block. For the lower clonidine dose pain ratings
decreased from 4.2 ± 0.8 in the PRE block to 4.2 ± 0.9
in POST block1 and 2.3 ± 1.4 in POST block2, which
was 53% of the PRE value. Again, there was a recovery
of the pain ratings to 3.2 ± 1.1 in POST block3,
3.6 ± 0.5 in POST block4 and 4.7 ± 1.6 in the REC
block. Although reductions of pain ratings generally
corresponded well to the reduction of SII dipolestrength, but the time course of pain ratings failed to
indicate a prolonged action of the higher clonidine dose.
Further statistical analysis substantiated these ﬁndings.
The results of the ANOVA (Table 2) yielded signiﬁcant
block eﬀects, for both the dipole strength (F = 8.7;
p < 0.05) and pain ratings (F = 7.2; p < 0.05), but no
main or interaction eﬀects occurred with dose on dipole
strength or pain ratings. Subsequent t-test analysis of
signiﬁcant ANOVA eﬀects is displayed in Table 3. When
compared with the pre-Block signiﬁcant reductions of
SII-dipole strength (Table 3A) and pain ratings (Table
3B) occurred for both clonidine doses in POST blocks
2, 3 and 4. The failure of change in post Block 1 is in
agreement with the pharmacokinetics of clonidine (Bisc-
hoﬀ et al., 2000). The half maximum value of clonidine
serum concentration is not reached before 10 min. No
correlations were found between dipole strengths (Q)
and pain ratings (Table 3C) with the one exception, sub-
ject KU.
Further analysis of the subjective eﬀects of clonidine
revealed an enhancement of tiredness and passiveness
during maximal clonidine concentration (Fig. 5). During
baseline the subjects rated their tiredness as 24.5 ± 18.1.
Sixty minutes after medication the tiredness was
enhanced to 63.3 ± 34.3 (258% of start value) which
lasted until 120 min after clonidine administration with
Fig. 4. Mean dipole strength values (A) and the pain ratings (B) with
standard error of the mean over all subjects. The dipole was ﬁxed in the
individual SII area for each subject (see Fig. 2). It is shown, that SII-
activity and the pain ratings are attenuated after clonidine application.
Table 2
Results of the ANOVA for the dipole strength (A) and pain ratings (B)
df F p p[e]
A. Dipole strength
Block 5 8.868 <0.001 0.008
Concentration 1 0.033 0.297 0.609
B. Pain rating
Block 5 7.244 <0.001 0.026
Concentration 1 0.318 0.597 0.597
A signiﬁcant block eﬀect (p < 0.001) with Greenhouse–Geisser-cor-
rection (p[e] < 0.008) for the dipole strength and the pain ratings
(p < 0.001; p[e] < 0.026) was found. No signiﬁcant eﬀect for concen-
tration was found either for the dipole strength (p = 0.609) nor for the
pain ratings (p = 0.597).
Table 3
Results of the t-tests for the dipole strength (A) and the pain ratings
(B)
1.5 lg/kg Clonidine 3.0 lg/kg Clonidine
t-Value p-Value t-Value p-Value
A. Dipole strength
Pre-post 1 2.69 0.021 1.17 0.147
Pre-post 2 2.83 0.018 3.19 0.012
Pre-post 3 4.72 0.002 3.03 0.015
Pre-post 4 3.81 0.006 2.21 0.039
Pre-rec 1.09 0.161 2.86 0.018
B. Pain rating
Pre-post 1 0.14 0.445 3.44 0.009
Pre-post 2 2.75 0.02 2.70 0.022
Pre-post 3 1.86 0.061 3.47 0.009
Pre-post 4 1.42 0.107 3.22 0.011
Pre-rec 1.02 0.178 1.68 0.076
r-Value p-Value n-Value
C. Correlation
HE (Q * PR) 0.453 0.139 12
KU (Q * PR) 0.942 <0.001 12
ME (Q * PR) 0.499 0.099 12
PR (Q * PR) 0.24 0.524 12
SA (Q * PR) 0.361 0.248 12
WA (Q * PR) 0.46 0.886 12
Clonidine reduces the SII-dipole strength and the pain ratings. A
correlation (C) between the dipole strength (Q) and the pain rating
(PR) for the single subjects was only found for subject KU.
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38.7 ± 23.8 before clonidine administration and chan-
ged to 59.3 ± 28.3 after 60 min (152.3% of the PRE
value) and 51.5 ± 30.7 after 120 min. Before low dose
clonidine administration the subjects rated their tired-
ness as 37.1 ± 32.5. After 60 min the tiredness was
enhanced to 64.5 ± 24.9 (171% of PRE value) which
recovered after 120 min to values of 32.2 ± 27.7. The
passiveness was rated as 33.0 ± 22.0 before clonidine
administration and changed to 50.8 ± 32.2 after
60 min (153.4% of the PRE value) and 32.5 ± 23.5 after
120 min.4. Discussion
By using an experimental pain model in six healthy
volunteers in combination with MEG measurements
this study demonstrates a substantial reduction of pain
intensity in parallel with decreased evoked activity in
the secondary somatosensory cortex (SII) following
administration of clonidine, at doses of 1.5 and 3.0 lg/
kg body weight. Dipole reconstruction based on the
individual brain morphology localized the induced mag-
netic activity maximum within a latency range from 90
to 120 ms reliably within the SII cortex in all subjects.
The intraindividual redetection accuracy was below
6 mm, which is the spatial resolution limit of our mea-
surements and calculations. Although both subjective
and physiological parameters of pain decreased after
clonidine they were not statistically correlated. This sup-
ports the idea that stimulus induced SII activity does not
necessarily reﬂect the painfulness of stimulation. Fur-
thermore, we could not ﬁnd any diﬀerences according
to the two doses of clonidin, which could indicate a ceil-
ing eﬀect on SII activity. Using the lower dose of 1.5 lg/
kg, the SII activity was already reduced to a minimum
value near the level of background noise as early as after
20 min post medication, from which no further reduc-
tion is possible. On the other hand the time course of
changes suggests a longer reduction of pain-induced
SII activity for the higher compared to the lower
Fig. 5. Results of the questionaire dealing with the individual feeling
of tiredness (above) and passiveness (below) of all subjects, 10 min
before the experiment and 60 and 120 min after it.
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of clonidine and ﬁndings of other authors (Bischoﬀ
et al., 2000, 2004).
Pain was induced by brief electrical current pulses,
which were applied intracutaneously by a tiny hole
through the horny layer of the middle ﬁngertip, thus
delivering the stimulus in the nearest neighbourhood
of cutaneous nociceptors. This model induces a distinct
pinprick pain and has shown its usefulness in many
experiments measuring pain and pain relief under eﬃ-
cient analgesics (for review see Bromm and Lorenz,
1998). But all experimental pain models co-activate
receptors of the tactile system as well, maybe also the
infrared laser heat pulse (Treede et al., 1995). There is
no doubt that tactile information reaches primary and
secondary somatosensory areas. Therefore experimental
pain-inducing stimuli always activate the SII cortex to a
higher or lower degree, as well as non-nociceptive aﬀer-
ents, thus activation of SII is not necessarily a sign for
pain experience (for a detailed discussion see Bromm
et al., 2000).
Earlier studies of our group demonstrated the eﬀects
of habituation and morphine on subjective pain and
pain evoked SII activity using the same intracutaneous
pain model in a placebo-controlled design (Quanteet al., 2004). Given these results that yielded only small
placebo eﬀects the investigated decrease of pain evoked
activity during the present study is likely due to the
administration of clonidine even though we decided
not to involve a placebo control in this study for proce-
dural reasons.
The observed reduction of experimental pain in this
study is consistent with clinical reports. Although pla-
cebo experiments are necessary to document new prop-
erties of drugs, and would have complemented our
ﬁndings for the purpose of this study, pre-post compar-
isons seemed suﬃcient. Furthermore these experiments
are extremely expensive and the mean values and nor-
mative variances of dipole identiﬁcations in SII are well
known within and between subjects from a huge number
of preceding experiments using the same standardized
design (Lorenz et al., 2005; Nakamura et al., 2002;
Bromm, 2001). However, the eﬀects due to the long ses-
sion duration are in the order of 5–8%. Because of this,
it is clear that clonidine in both concentrations attenu-
ates the SII activity drastically by 50% or more. Thus,
the question is how clonidine interacts so strongly with
pain perception. For example, in postoperative pain
management intrathecal application of clonidine is used
successfully to reduce the dose of morphine (Eisenach
et al., 2000; Kanui et al., 1993; for review see Bischoﬀ
and Kochs, 1993). Studies in animals and patients have
shown that the transdermal, epidural and intravenous
administration of clonidine reduces pain intensity in
neuropathic pain syndromes for periods varying from
some hours up to 1 month. However, there is little evi-
dence for a speciﬁc antinociceptive eﬀect of intravenous
administered clonidine (Bernard et al., 1995; Eisenach
et al., 1998; Hao et al., 1996). These authors conclude
that the clonidine-related decrease in pain experience
depends on the level of arousal and is most probably
not due to direct actions on the nociceptive system
(see also Kakigi et al., 1996; Ha¨ma¨la¨inen et al., 2000;
Ho¨chstetter et al., 2000; Nakamura et al., 2002). On
the other hand, it is well known that SII activity depends
on the vigilance level and on attentional states of the
subject under investigation (Mima et al., 1998; Sarter
et al., 2001; Nakamura et al., 2002). Obviously the SII
cortex is tonically pre-primed by subcortical regions,
which control the state of vigilance and arousal. Seda-
tives, tranquilizers and hypnotics attenuate stimulus
evoked SII activity as well as mental distraction from
the stimulus event. Also clonidine is well known to
reduce vigilance and arousal (Bischoﬀ and Kochs,
1993; Coull et al., 1995; Clark et al., 1986). Analysis of
the spontaneous electroencephalogram (EEG) supports
these observations. Clonidine attenuates the alpha
rhythm and increases slow theta and delta rhythms
(Bischoﬀ et al., 2000), parameters that are well known
to correlate with reaction time and subjective fatigue.
A limitation of our study is that we only evaluated sub-
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out raising reaction times or other clinical parameters
of sedation and directly relate this to the action of cloni-
dine on the SII cortex. For this reason we cannot clearly
diﬀerentiate between speciﬁc and unspeciﬁc modulations
of pain induced SII activity, a question that need to be
addressed in further studies with greater focus on multi-
modal assessment of sedation in comparison with MEG
and EEG. Nevertheless, we were able to show, that clo-
nidine decreases pain ratings and pain evoked SII activ-
ity allowing the conclusion that intravenous clonidine,
and not only intrathecal clonidine, is able to relieve pain,
but the detailed cortical mechanisms of intravenous clo-
nidine on the pain system remains unclear.5. Conclusions
Intravenous administration of clonidine was able to
reduce pain evoked SII activity (decrease from PRE =
100% to POST2 = 22%) and pain ratings (decrease from
PRE = 100% to POST2 = 48%), without signiﬁcant cor-
relation between these parameters. Similarly an increase
of tiredness (258%) and passiveness (152.3%) was
observed. Therefore, not only the intrathecal, but also
the intravenous application of clonidine suppresses pain.
Given the close association of pain perception and vigi-
lance, the observed attenuation of pain evoked
responses, represented at the level of the SII cortex,
can be explained by a reduction of vigilance and arousal,
eﬀects of clonidine that have been reported earlier and
something for which clonidine is well known. Further
studies using physiological indicators of sedation in
combination with those of pain can better discriminate
the relative contribution of unspeciﬁc sedative and spe-
ciﬁc analgesic clonidine actions.Acknowledgements
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